Search

Your search keyword '"Meylan, M."' showing total 472 results

Search Constraints

Start Over You searched for: Author "Meylan, M." Remove constraint Author: "Meylan, M."
472 results on '"Meylan, M."'

Search Results

1. On the Wiener-Hopf solution of water-wave interaction with a submerged elastic or poroelastic plate

3. Bragg-Edge Elastic Strain Tomography for in situ Systems from Energy-Resolved Neutron Transmission Imaging

10. 184P Elevated baseline circulating IL-8 is associated with increased expression of the IMmotion myeloid gene signature (GS) in metastatic clear cell renal cell carcinoma (mRCC) patients (pts) treated with nivolumab (nivo) within the NIVOREN GETUG-AFU 26 study

19. Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy

25. 1451MO In-situ immune markers predict nivolumab (N) +/-ipilimumab (I) efficacy in frontline metastatic clear cell renal cell carcinoma (mccRCC): Key ancillary analyses from the BIONIKK randomized trial

27. Effect of static compression on tsunami waves: Two-dimensional solution.

28. Antimicrobial susceptibility in E. coli and Pasteurellaceae at the beginning and at the end of the fattening process in veal calves: Comparing ‘outdoor veal calf’ and conventional operations

31. [Evaluation of associations between barn characteristics, results of barn climate parameter measurements and health indicators in Swiss veal calf herds]

33. Potential of a rumen bolus containing 1,25-dihydroxyvitamin D3 glycosides for the prevention of hypocalcaemia in primiparous and multiparous dairy cows

34. Prevalence of multidrug resistance in Escherichia coli in the immediate calves' environment in Swiss dairy farms

37. Storm-induced sea-ice breakup and the implications for ice extent

40. 687P NIVOREN GETUG-AFU 26 translational study: Baseline peripheral cytokines predict survival in metastatic clear cell renal carcinoma (RCC) treated with nivolumab

41. 689P Human leukocyte antigen (HLA) class I/II expression as a predictive biomarker for response to immune oncology (IO) therapy in metastatic clear-cell renal cell carcinoma (m-ccRCC)

43. NIVOREN GETUG-AFU 26 translational study: Baseline peripheral cytokines predict survival in metastatic clear cell renal carcinoma (RCC) treated with nivolumab

44. [Untitled]

45. Human leukocyte antigen (HLA) class I/II expression as a predictive biomarker for response to immune oncology (IO) therapy in metastatic clear-cell renal cell carcinoma (m-ccRCC)

46. Optimization of the cross section of a novel rail running conveyor system.

Catalog

Books, media, physical & digital resources